CANTON, Mich. (August 28, 2020)– MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that Uma Sharma, Ph.D., Founder and Chief Scientific Officer of MMS, has been invited to join the board of directors with MichBio – a trade association committed to driving growth in Michigan’s biosciences industry and its many sectors for more than 20 years. Dr. Sharma will serve on the board from August 2020 to December 2021.
Uma will represent MMS alongside other local bioscience industry leaders, including peers from Neogen, Wayne State University, University of Michigan, Emergent BioSolutions, Medbio, the Michigan Economic Development Corporation (MEDC), and several others.
“It is a pleasure for me to join a board where we can further the excellence and integrity of the pharmaceutical, biotech, and medical device industries in Michigan and across the world,” says Dr. Sharma. “Our goal is to improve the lives of people globally through strong science, innovative technology, and a sense of urgency, and I look forward to bringing this same line of advanced thinking to my duties as part of the MichBio board.”
In this role, Uma will lend her expertise and guidance to MichBio as they continue to effectively promote and advance the common goals and concerns of Michigan’s bio-industry. According to MichBio, there are currently more than 40,000 people and 1,700 bio-industry companies in Michigan that help change, improve, and save lives.
“The goal of MichBio is to help the Michigan bioscience sector define the future, and Dr. Uma Sharma and her global team of experts at MMS play a strong role in that,” says Stephen Rapundalo, Ph.D., President & CEO, MichBio, “With her expansive background, success, and knowledge in the industry, the board is elated to welcome Uma. She is a consistent leader and uniquely positioned to understand the challenges that today’s biotech and research industries face. I know her insights will help us to promote the Michbio goals forward.”
In 2019, Dbusiness Magazine recognized Uma as a Champion of the New Economy. To learn more about MMS leadership in the pharmaceutical industry, go here: Executive leadership
About MMS Holdings
MMS is an award-winning, data and technologies-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards and Most Outstanding CRO in the 2019 Biotechnology Awards.
For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
Our mission encompasses broad industry sub-sector representation including pharmaceuticals and therapeutics (human and animal health, generics and OTCs), medical devices, diagnostics, research tools, informatics (healthcare and bio-informatics), nutritional health (nutriceuticals), clinical research, industrial biotechnology, and bio-fuels and bio-agriculture.
For more information, visit www.michbio.org.